References
- ChlebowskiRTAndersonGLGassMEstrogen plus progestin and breast cancer incidence and mortality in postmenopausal womenJAMA2010304151684169220959578
- American College of Obstetricians and Gynecologists Committee on Gynecologic PracticeACOG Committee Opinion No. 420, November 2008: hormone therapy and heart diseaseObstet Gynecol200811251189119218978127
- SantoroNKomiJPrevalence and impact of vaginal symptoms among postmenopausal womenJ Sex Med2009682133214219493278
- IMS2008 US sales and prescription information. [Data from IMS Health’s DDA Service.]Danbury, CTIMS Health2009 Available from: http://www.imshealth.com
- North American Menopause SocietyEstrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause SocietyMenopause201017224225520154637
- MoralesLNevenPTimmermanDAcute effects of Tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patientsAnticancer Drugs200415875376015494636
- BaumgartJNilssonKStavreus-EversAUrogenital disorders in women with adjuvant endocrine therapy after early breast cancerAm J Obstet Gynecol2011204126. e1e720950790
- BachmannGAKomiJOOspemifene Study GroupOspemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 studyMenopause201017348048620032798
- QuatRx™Ophena™ (ospemifene) [web page on the Internet]Ann Arbor, MIQuatRx; nd Available from: http://www.quatrx.com/clinical/ospem.htmAccessed September 17, 2010
- KaganRWilliamsRSPanKMirkinSPickarJHA randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal womenMenopause201017228128919779382
- LevineJPTreating menopausal symptoms with tissue-selective estrogen complexGend Med201182576821536225
- LabrieFArcherDBouchardCIntravaginal dehydroepiandrosterone (Prasterone), a physiological and healthy efficient treatment of vaginal atrophyMenopause200916590792219436225
- LabrieFArcherDBouchardCIntravaginal dehydroepiandrosterone (Prasterone), a highly effective efficient treatment of dyspareuniaClimacteric201114228228821244215
- EndoCeutics IncDehydroepiandrodrosterone (DHEA) against vaginal atrophyClinicalTrialsgov [website on the Internet]Bethseda, MDUS National Library of Medicine2011 [updated July 29, 2011]. Available from: http://clinicaltrials.gov/ct2/show/NCT01358760?term=NCT01358760&rank=1Accessed September 14, 2011
- GradyDSawayaGFJohnsonKCMF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trialMenopause200916345846519182698
- BionovoVG101 Phase I/II to treat vulvar and vaginal atrophy in post-menopausal womenClinicalTrialsgov [website on the Internet]Bethseda, MDUS National Library of Medicine2007 [updated June 6, 2011]. Available from: http://clinicaltrials.gov/ct2/show/NCT00453089?term=NCT00453089&rank=1NLM identifier: NCT00453089Accessed September 14, 2011
- Mayo ClinicA trial to evaluate the efficacy of low dose vaginal estrogens in the treatment of atrophic vaginitisClinicalTrialsgov [website on the Internet]Bethseda, MDUS National Library of Medicine2008 [updated May 2, 2011]Available from: http://clinicaltrials.gov/ct2/show/NCT00816556?term=NCT00816556&rank=1NLM identifier: NCT00816556Accessed September 14, 2011